0001493152-24-015812.txt : 20240424 0001493152-24-015812.hdr.sgml : 20240424 20240424170026 ACCESSION NUMBER: 0001493152-24-015812 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240422 FILED AS OF DATE: 20240424 DATE AS OF CHANGE: 20240424 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tapolczay David CENTRAL INDEX KEY: 0001991789 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41245 FILM NUMBER: 24871366 MAIL ADDRESS: STREET 1: 32 CROUCH HALL LANE CITY: ST. ALBANS STATE: X0 ZIP: AL3 7EU ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONDUIT PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001896212 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 873272543 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4995 MURPHY CANYON ROAD, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92123 BUSINESS PHONE: (760) 471 8536 MAIL ADDRESS: STREET 1: 4995 MURPHY CANYON ROAD, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92123 FORMER COMPANY: FORMER CONFORMED NAME: Murphy Canyon Acquisition Corp. DATE OF NAME CHANGE: 20211130 4 1 ownership.xml X0508 4 2024-04-22 0 0001896212 CONDUIT PHARMACEUTICALS INC. CDT 0001991789 Tapolczay David 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 1 1 0 0 Chief Executive Officer 0 Warrant (Right to buy) 3.12 2024-04-22 4 A 0 400664 A 2025-04-22 2027-04-22 Common Stock 400664 400664 D Warrant (Right to buy) 3.12 2024-04-22 4 S 0 200332 D 2025-04-22 2027-04-22 Common Stock 200332 200332 D Warrants issued in exchange for one year lock-up of reporting person's common stock of the company, par value $0.0001 per share, and the payment of $0.125 per warrant. Warrants sold in exchange for $0.25 per warrant in private transaction. /s/ David Tapolczay 2024-04-24